Sign Up Now to Download a Free Research Report on

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals shares soared 23.91 percent on volume of over 22 million shares traded Thursday to close at $8.24 a share. The company announced that they reported positive results from a Phasse III study of their Parkinson’s drug, pimavanserin, at the American Academy of Neurology Annual Meeting.

Going forward ... (see research report)



RESEARCH REPORT ON Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on